Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$162.42 - $220.56 $738,036 - $1 Million
-4,544 Reduced 27.17%
12,180 $2.06 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $2.68 Million - $4.28 Million
16,724 New
16,724 $3.13 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $11.3 Million - $18.1 Million
-70,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $2.43 Million - $4.05 Million
-12,500 Reduced 15.15%
70,000 $20.2 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $12.2 Million - $17 Million
82,500 New
82,500 $15.8 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.